IP Library Granted Patent US 11,696,763
Granted Patent B2
US 11,696,763 · App. 16/532,820 · Granted Jul 11, 2023

Collateral flow channel sealant delivery methods and systems

Inventors: Sri Radhakrishnan (Cupertino, CA); Ryan Olivera (Granite Bay, CA)
Assignee: Pulmonx Corporation
A61B17/12104A61B5/08A61B5/4848A61B17/1204A61B17/12136A61M16/042A61M16/0406A61M16/0459A61M25/0147A61M25/10A61F2002/043A61F2250/0067A61M2025/0001A61M2202/0413A61M2202/0468A61M2205/502
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,696,763
App. No.
16/532,820
Granted
Jul 11, 2023
Kind
B2
Abstract

Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.

Claims (27)

1. A method for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment, said method comprising:

inserting a video-assisted thoracoscopic device into a thoracic cavity of a patient;

inserting a cutting device through an incision on the chest of the patient into the thoracic cavity; and

cutting tissue at a collateral flow channel between a target lung compartment and an adjacent lung compartment using the cutting device from the thoracic cavity thereby disrupting the collateral flow channel.

2. The method of claim 1 further comprising stapling, suturing, or gluing the cut tissue.

3. The method of claim 1 further comprising identifying the collateral flow channel using the video-assisted thoracoscopic device.

4. A method as in claim 1 , further comprising placing an endobronchial valve within an airway leading to the target lung compartment.

5. A method as in claim 4 , wherein the endobronchial valve is a one-way flow control valve configured to allow air to flow out of the target lung compartment and prevent air flow into the target lung compartment.

6. A method for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment, said method comprising:

inserting a video-assisted thoracoscopic device into a thoracic cavity of a patient;

inserting a needle through an incision on the chest of the patient into the thoracic cavity and through tissue forming a collateral flow channel between a target lung compartment and an adjacent lung compartment; and

injecting an agent through the needle and into the collateral flow channel, thereby reducing the collateral flow channel.

7. The method of claim 6 further comprising placing a clip on the collateral channel thereby pinching closed the collateral channel.

8. The method of claim 6 , further comprising cutting tissue at the collateral flow channel thereby disrupting the collateral flow channel.

9. The method of claim 6 , wherein the agent is a sealant.

10. The method of claim 6 , wherein the agent is a sclerosing agent.

11. The method of claim 6 , wherein the agent is autologous blood.

12. The method of claim 6 further comprising identifying the collateral flow channel using the video-assisted thoracoscopic device.

13. A method as in claim 6 , further comprising placing an endobronchial valve within an airway leading to the target lung compartment.

14. A method as in claim 13 , wherein the endobronchial valve is a one-way flow control valve configured to allow air to flow out of the target lung compartment and prevent air flow into the target lung compartment.

15. A method for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment, said method comprising:

inserting a video-assisted thoracoscopic device into a thoracic cavity of a patient;

inserting a closing device into the thoracic cavity of the patient; and

clipping, stapling, or suturing tissue at a collateral flow channel between a target lung compartment and an adjacent lung compartment using the closing device from the thoracic cavity thereby disrupting the collateral flow channel.

16. The method of claim 15 further comprising identifying the collateral flow channel using the video-assisted thoracoscopic device.

17. A method as in claim 15 , further comprising placing an endobronchial valve within an airway leading to the target lung compartment.

18. A method as in claim 17 , wherein the endobronchial valve is a one-way flow control valve configured to allow air to flow out of the target lung compartment and prevent air flow into the target lung compartment.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2019
From: RADHAKRISHNAN, SRI; OLIVERA, RYAN
To: PULMONX CORPORATION
Reel/Frame 051193/0648 →